GRIM-19 function in cancer development

Mitochondrion. 2011 Sep;11(5):693-9. doi: 10.1016/j.mito.2011.05.011. Epub 2011 Jun 2.

Abstract

Cancer development involves multiple genetic changes, which can occur in tumor suppressor genes and lead to loss of function in a recessive manner. Recent findings have identified a novel tumor suppressor gene named GRIM-19. Similar to what has been observed for other known tumor suppressor proteins such as p53, GRIM-19 gene mutations and loss of protein expression have been observed in several tumor types. In this review, we perform a detailed description on the current understanding of GRIM-19 function in carcinogenesis.

Publication types

  • Review

MeSH terms

  • Animals
  • Apoptosis Regulatory Proteins / genetics
  • Apoptosis Regulatory Proteins / metabolism*
  • Cell Transformation, Neoplastic / metabolism*
  • Cyclin-Dependent Kinase Inhibitor p16 / metabolism
  • Electron Transport
  • Gene Expression
  • Granulocyte Colony-Stimulating Factor / metabolism
  • Humans
  • Mitochondrial Proteins / genetics
  • Mitochondrial Proteins / metabolism*
  • NADH, NADPH Oxidoreductases / genetics
  • NADH, NADPH Oxidoreductases / metabolism*
  • Neoplasms / metabolism*
  • Neoplasms / pathology
  • STAT3 Transcription Factor / metabolism

Substances

  • Apoptosis Regulatory Proteins
  • Cyclin-Dependent Kinase Inhibitor p16
  • Mitochondrial Proteins
  • OLFM4 protein, human
  • STAT3 Transcription Factor
  • Granulocyte Colony-Stimulating Factor
  • NADH, NADPH Oxidoreductases
  • NDUFA13 protein, human